» Articles » PMID: 15692259

Virchow's Triad Revisited: Blood Constituents

Overview
Publisher Karger
Date 2005 Feb 5
PMID 15692259
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

An update of Virchow's triad for thrombogenesis can be considered by reference to abnormalities in the endothelium/endocardium ('abnormal vessel wall'), abnormalities of haemorhelogy and turbulence at bifurcations,atheroma at vessel wall ('abnormal bloodflow') and abnormalities in platelet as well as the coagulation and fibrinolytic pathways ('abnormal blood constituents'). The constituents of the blood are many and varied, but soluble coagulation factors (such as fibrinogen and tissue factor) and cells (such as platelets)are clearly important. Clearly, 'a continuum exists between health, 'statistically' increased haemostatic abnormalities in prothrombotic or hypercoagulable states and 'overtly' increased clotting in acute thrombosis.Thus, the patients with the highest levels of the markers appear to be the highest risk of disease progression,and if so, a panel of 'high risk' blood constituent indices (platelet and coagulation markers) may potentially give a composite score of risk, and may be a useful tool in predicting subjects at highest risk. Further longitudinal studies are clearly required. There is no doubt that Virchow would be impressed on how his classical triad has expanded to encompass the wide range of pathophysiological processes leading to thrombogenesis.

Citing Articles

The impact of thrombophilia on in-hospital outcomes in patients with acute coronary syndrome: insights from the United States National Inpatient Sample.

Kwok C, Gibbs T, Majeed M, Borovac J, Will M, Schwarz K J Thromb Thrombolysis. 2025; 58(2):178-187.

PMID: 39954039 DOI: 10.1007/s11239-025-03068-4.


Assessment of Coagulation Factors in Patients with Severe Rheumatic Mitral Stenosis in Sinus Rhythm with Left Atrial Appendage Inactivity.

Mukhopadhyay S, Chauhan N, Muheeb G, Yusuf J, Mehta V, Mahajan B CJC Open. 2024; 6(10):1231-1239.

PMID: 39525339 PMC: 11544275. DOI: 10.1016/j.cjco.2024.07.004.


Transformative Deep Vein Thrombosis Prophylaxis With Sequential Compression Devices in the Care of Hospitalized Patients.

Shahbaz A, Wannakuwatte R, Mohammed C, Alzarooni A, Pendem H, Majeed F Cureus. 2024; 16(10):e70639.

PMID: 39483555 PMC: 11526840. DOI: 10.7759/cureus.70639.


Effects of on Human Umbilical Vein Endothelial Cells.

Kruger-Genge A, Harb K, Braune S, Jung C, Westphal S, Bar S Life (Basel). 2024; 14(10).

PMID: 39459553 PMC: 11508656. DOI: 10.3390/life14101253.


Subclinical leaflet thrombus in patients with severe aortic stenosis and atrial fibrillation -ENRICH-AF TAVI study.

Otsuka Y, Ishii M, Tabata N, Oda S, Kidoh M, Shirahama Y Sci Rep. 2024; 14(1):14902.

PMID: 38942790 PMC: 11213935. DOI: 10.1038/s41598-024-65600-5.